VanEck Associates’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-173,535
| Closed | -$3.39M | – | 1460 |
|
|
2022
Q4 | $3.39M | Buy |
173,535
+1,763
| +1% | +$34.4K | 0.01% | 558 |
|
|
2022
Q3 | $3.59M | Buy |
171,772
+25,021
| +17% | +$523K | 0.01% | 513 |
|
|
2022
Q2 | $4.7M | Buy |
146,751
+21,938
| +18% | +$703K | 0.01% | 476 |
|
|
2022
Q1 | $5.09M | Sell |
124,813
-6,997
| -5% | -$285K | 0.01% | 501 |
|
|
2021
Q4 | $5.89M | Buy |
131,810
+5,635
| +4% | +$252K | 0.01% | 472 |
|
|
2021
Q3 | $6.29M | Buy |
126,175
+14,951
| +13% | +$746K | 0.02% | 429 |
|
|
2021
Q2 | $5.97M | Sell |
111,224
-7,923
| -7% | -$425K | 0.01% | 433 |
|
|
2021
Q1 | $5.47M | Buy |
119,147
+10,802
| +10% | +$496K | 0.01% | 427 |
|
|
2020
Q4 | $5.29M | Buy |
108,345
+4,454
| +4% | +$218K | 0.02% | 372 |
|
|
2020
Q3 | $4.61M | Sell |
103,891
-2,218
| -2% | -$98.4K | 0.01% | 354 |
|
|
2020
Q2 | $4.08M | Sell |
106,109
-5,505
| -5% | -$212K | 0.01% | 363 |
|
|
2020
Q1 | $4.59M | Buy |
+111,614
| New | +$4.59M | 0.02% | 322 |
|